The scientific journal, Nutrition Research, recently published the latest results on WEIGHTAIN— a satiety ingredient manufactured by Ingredion Incorporated. The new research clearly demonstrates that WEIGHTAIN satiety ingredient significantly lowered both post-breakfast and post-lunch glycemic and insulin responses relative to the control. While previous research has highlighted the satiety benefit of WEIGHTAIN satiety ingredient, this is the first study to demonstrate a glycemic benefit for the ingredient.
The study was also unique in that it showed WEIGHTAIN satiety ingredient was clinically effective when incorporated into two different food applications. One part of the study compared glycemic responses in a frozen berry smoothie for breakfast — made with either the control (maltodextrin) or WEIGHTAIN satiety ingredient — among healthy men and women. The second part of the study was identical to the smoothie study except subjects consumed cold-pressed bars for breakfast with either the maltodextrin control or WEIGHTAIN satiety ingredient.